I am excited to share a deeper look into my professional journey across global pharmaceutical and biotechnology leadership. Over the past several decades, I have been fortunate to support groundbreaking therapies in oncology, rare diseases, diagnostics, and radiopharmaceuticals, always guided by my commitment to putting patients first. Here is my biography.

Mary Hames is a seasoned Medical Affairs executive with a proven track record of leading high-performing teams and delivering strategic impact across rare disease, diagnostics, and oncology. With a foundation in biochemical genetics and over a decade of industry experience, she has played pivotal roles in clinical operations, launch preparedness, and cross-functional leadership. Known for her ability to navigate complex medical landscapes, Mary has successfully built and led medical teams, advanced companion diagnostics, and driven field strategy across multiple therapeutic areas. Her leadership is marked by scientific rigor, operational excellence, and a deep commitment to improving outcomes for patients with rare and life-threatening conditions.